+
Learn How Prisma Delivered Tangible Business Value for KPMG
Prisma identified previously undetected risks in the AI system used by KPMG, including a 13.89% chance of hallucination, a 6% influence from 'tone of input', and a 5% influence from 'clarify of input'. The average accuracy fell significantly, at 37.12% in certain environments and 55.78% in specific projects, indicating contextual limitations of the AI.
AI-Powered Diagnostics & Personalized Medicine
Tracking Behavioral Drift in AI Systems
Compliance Assurance in Medical Communications
Automated QA for Regulatory & Ethical Compliance
AI-Powered Diagnostics & Personalized Medicine systems used in medical diagnostics or treatment recommendations evolve with new data—but unintended drift can lead to misinterpretations or deviations from clinical guidelines. Prisma helps healthcare teams stay ahead by flaging inconsistencies in algorithmic recommendations and ensuring AI models align with industry AI standards.
Healthcare and pharmaceutical companies must meet strict regulatory guidelines in communications—whether patient-facing, medical research-related, or compliance-driven. Prisma ensures accuracy and adherence at scale by reviewing medical documentation, clinical trial reports, and promotional materials and flaging missing disclosures, inaccuracies, or ambiguous statements.
Regulatory Adherence Monitoring
AI Governance for Clinical & Regulatory Decision-Making
AI-Assisted Drug Safety & Clinical Trial Evaluation plays a crucial role in drug development, clinical trials, and post-market safety monitoring.
Prisma ensures AI-driven assessments remain transparent, compliant, and bias-free, detecting potential bias in AI-supported patient risk profiling and providing structured audit reporting.
Have Experts in the Loop only when necessary
Gain instant visibility into your AI system's performance. Receive timely alerts and notifications, allowing you to take immediate action and mitigate any risks.
TRUSTED BY INDUSTRY LEADERS AND POLICYMAKERS
